Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
CTF1 |
cardiotrophin 1 |
Mapped by CNV |
TAS[7738033]
|
PELO |
pelota homolog (Drosophila) |
Mapped by LD-proxy; Mapped by literature SNP |
|
PLK1 |
polo-like kinase 1 |
Mapped by significant region |
TAS[8127874]
|
CCKBR |
cholecystokinin B receptor |
Mapped by CNV; Mapped by PBA pathway |
TAS[10400698]
|
ZNF259 |
zinc finger protein 259 |
Mapped by significant region |
TAS[9763455]
|
FES |
feline sarcoma oncogene |
Mapped by LD-proxy |
TAS[6264598]
|
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
Mapped by significant region |
TAS[9447981]
|
MAPRE1 |
microtubule-associated protein, RP/EB family, member 1 |
Mapped by PBA pathway |
TAS[7606712]
|
YAP1 |
Yes-associated protein 1 |
Mapped by significant region |
IDA[17974916]
|
SYK |
spleen tyrosine kinase |
Mapped by significant region |
TAS[10963601]
|
OCA2 |
oculocutaneous albinism II |
Mapped by CNV; Mapped by significant region |
|
XRCC5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) |
Mapped by significant region |
|
IFLTD1 |
intermediate filament tail domain containing 1 |
Mapped by CNV |
|
KIF2C |
kinesin family member 2C |
Mapped by PBA pathway |
TAS[9434124]
|
SKP2 |
S-phase kinase-associated protein 2 (p45) |
Mapped by significant region |
TAS[7553852]
|
CKS2 |
CDC28 protein kinase regulatory subunit 2 |
Mapped by significant region |
TAS[8211159]
|
TXN |
thioredoxin |
Mapped by significant region |
TAS[3170595]
|
PEMT |
phosphatidylethanolamine N-methyltransferase |
Mapped by significant region |
TAS[9989271]
|
PRKD1 |
protein kinase D1 |
Mapped by significant region |
TAS[8119958]
|
EDNRA |
endothelin receptor type A |
Mapped by PBA pathway |
NAS[9284755]
|
MS4A2 |
membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide) |
Mapped by PBA pathway; Mapped by significant region |
TAS[2448768]
|
SIPA1 |
signal-induced proliferation-associated 1 |
Mapped by significant region |
TAS[9346962]
|
SLC29A2 |
solute carrier family 29 (nucleoside transporters), member 2 |
Mapped by significant region |
TAS[7639753]
|
TBX1 |
T-box 1 |
Mapped by CNV |
|
RRN3 |
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) |
Mapped by CNV; Mapped by significant region |
|
CD5 |
CD5 molecule |
Mapped by significant region |
NAS[3093892]
|
MAP3K11 |
mitogen-activated protein kinase kinase kinase 11 |
Mapped by significant region |
IMP[15258589]
|
BCAR1 |
breast cancer anti-estrogen resistance 1 |
Mapped by significant region |
TAS[10639512]
|
PLCE1 |
phospholipase C, epsilon 1 |
Mapped by PBA pathway |
NAS[11022048]
|
REG1B |
regenerating islet-derived 1 beta |
Mapped by CNV |
TAS[2963000]
|
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Mapped by LD-proxy |
TAS[10851066]
|
ROS1 |
c-ros oncogene 1 , receptor tyrosine kinase |
Mapped by significant region |
|
REG3A |
regenerating islet-derived 3 alpha |
Mapped by CNV |
TAS[8997243]
|
DAB2 |
disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) |
Mapped by significant region |
TAS[9620555]
|
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
Mapped by significant region |
TAS[8391931]
|
GLUL |
glutamate-ammonia ligase |
Mapped by significant region |
IDA[18662667]
|
PAK7 |
p21 protein (Cdc42/Rac)-activated kinase 7 |
Mapped by CNV |
|
KDM1A |
lysine (K)-specific demethylase 1A |
Mapped by LD-proxy |
|
ACHE |
acetylcholinesterase |
Mapped by PBA pathway |
TAS[11283752]
|
CHRM1 |
cholinergic receptor, muscarinic 1 |
Mapped by PBA pathway; Mapped by significant region |
TAS[1905013]
|
MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
Mapped by CNV |
IDA[12782713]
|
MAPRE2 |
microtubule-associated protein, RP/EB family, member 2 |
Mapped by significant region |
TAS[9233623]
|
CUL5 |
cullin 5 |
Mapped by PBA pathway; Mapped by significant region |
TAS[9037604]
|
IL5RA |
interleukin 5 receptor, alpha |
Mapped by CNV |
TAS[1732409]
|
CHRM5 |
cholinergic receptor, muscarinic 5 |
Mapped by CNV; Mapped by PBA pathway |
TAS[8063729]
|
NPY |
neuropeptide Y |
Mapped by CNV; Mapped by significant region |
TAS[10488139]
|
NR6A1 |
nuclear receptor subfamily 6, group A, member 1 |
Mapped by significant region |
TAS[9134503]
|
GOLPH3 |
golgi phosphoprotein 3 (coat-protein) |
Mapped by significant region |
IMP[19553991]
|
CHRM3 |
cholinergic receptor, muscarinic 3 |
Mapped by CNV; Mapped by PBA pathway |
TAS[8063729]
|
USP28 |
ubiquitin specific peptidase 28 |
Mapped by significant region |
IMP[17558397]
|
TYR |
tyrosinase (oculocutaneous albinism IA) |
Mapped by significant region |
|
ILK |
integrin-linked kinase |
Mapped by CNV |
NAS[10871859]
|
OSMR |
oncostatin M receptor |
Mapped by significant region |
TAS[8999038]
|
LIPG |
lipase, endothelial |
Mapped by PBA pathway |
|
MRE11A |
MRE11 meiotic recombination 11 homolog A (S. cerevisiae) |
Mapped by significant region |
|